Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gabay

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Arthritis and Rheumatism|March 7, 2001
Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritisC Gabay, L Marinova-Mutafchieva, R O Williams, et al.
Annals of the Rheumatic Diseases|May 7, 2009
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?A Finckh, A Ciurea, L Brulhart, et al.
Arthritis and Rheumatism|December 1, 1994
Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein responseC Gabay, F Gay-Croisier, P Roux-Lombard, et al.
The Journal of Rheumatology|February 1, 1997
Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activityC Gabay, N Cakir, F Moral, et al.
The Journal of Rheumatology|August 1, 1997
Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluidA Desgeorges, C Gabay, P Silacci, et al.
Clinical and Experimental Rheumatology|November 18, 2009
Relationship between gamma-interferon and interleukin-17 in Chlamydia trachomatis reactive arthritisS Bas, L Neff, S Viatte, et al.
Nature|November 9, 2001
Asynchronous replication and allelic exclusion in the immune systemR Mostoslavsky, N Singh, T Tenzen, et al.
Molecular Medicine (Cambridge, Mass.)|November 7, 1999
Peptidomimetic fluoromethylketone rescues mice from lethal endotoxic shockS R Grobmyer, R C Armstrong, S C Nicholson, et al.
RMD Open|May 10, 2020
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in SwitzerlandA Finckh, C Tellenbach, L Herzog, et al.
Vaccine|January 9, 2020
Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individualsJ Burkhard, A Ciurea, C Gabay, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Arthritis and Rheumatism|March 7, 2001
Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritisC Gabay, L Marinova-Mutafchieva, R O Williams, et al.
Annals of the Rheumatic Diseases|May 7, 2009
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?A Finckh, A Ciurea, L Brulhart, et al.
Arthritis and Rheumatism|December 1, 1994
Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein responseC Gabay, F Gay-Croisier, P Roux-Lombard, et al.
The Journal of Rheumatology|February 1, 1997
Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activityC Gabay, N Cakir, F Moral, et al.
The Journal of Rheumatology|August 1, 1997
Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluidA Desgeorges, C Gabay, P Silacci, et al.
Clinical and Experimental Rheumatology|November 18, 2009
Relationship between gamma-interferon and interleukin-17 in Chlamydia trachomatis reactive arthritisS Bas, L Neff, S Viatte, et al.
Nature|November 9, 2001
Asynchronous replication and allelic exclusion in the immune systemR Mostoslavsky, N Singh, T Tenzen, et al.
Molecular Medicine (Cambridge, Mass.)|November 7, 1999
Peptidomimetic fluoromethylketone rescues mice from lethal endotoxic shockS R Grobmyer, R C Armstrong, S C Nicholson, et al.
RMD Open|May 10, 2020
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in SwitzerlandA Finckh, C Tellenbach, L Herzog, et al.
Vaccine|January 9, 2020
Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individualsJ Burkhard, A Ciurea, C Gabay, et al.
Pageof 10